A genome-wide linkage scan in German shepherd dogs localizes canine platelet procoagulant deficiency (Scott syndrome) to canine chromosome 27

Gene

Volumn 450, Issue 1-2, 2010, Pages 70-75

  Brooks, Marjory ^a   Etter, Krystal ^a   Catalfamo, James ^a   Brisbin, Abra ^b   Bustamante, Carlos ^b   Mezey, Jason ^b  

^a Department of Obstetrics Gynecology   (United States)

^b Plant Breeding and Genetics Section in the School of Integrative Plant Science   (United States)

Author keywords

Blood phospholipids; Disease model; Dog genetic disease; Platelet activation

Indexed keywords

PROTHROMBIN;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CENTROMERE; CHROMOSOME; CHROMOSOME 27; CONTROLLED STUDY; DOG; FEMALE; FLOW CYTOMETRY; GENETIC LINKAGE; GENOTYPE; LINKAGE ANALYSIS; MALE; MICROSATELLITE MARKER; NONHUMAN; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; SCOTT SYNDROME; THROMBOCYTE FUNCTION;

ANIMALS; BLOOD PLATELETS; CHROMOSOMES, MAMMALIAN; DOG DISEASES; DOGS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEMORRHAGE; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; PEDIGREE; PROTHROMBIN TIME; SYNDROME;

ANIMALIA; CANIS FAMILIARIS;

EID: 72449203091     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2009.09.016     Document Type: Article

References (39)

1. Albrecht C, et al. A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome. Blood. 2005, 106:542-549.
2. Augereau O, et al. Apoptotic-like mitochondrial events associated to phosphatidylserine exposure in blood platelets induced by local anaesthetics. Thromb. Haemost. 2004, 92:104-113.
3. Baines C.P, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 2005, 434:658-662.
4. Bateman A, et al. Phospholipid scramblases and Tubby-like proteins belong to a new superfamily of membrane tethered transcription factors. Bioinformatics. 2009, 25:159-162.
5. Bevers EM, Comfurius P, Zwaal RF. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev. 1991, 5:146-154.
6. Boudreaux, M.K., 2008. Characteristics, diagnosis, and treatment of inherited platelet disorders in mammals. J. Am. Vet. Med. Assoc. 233, 1251-9, 1190.
7. Brooks M. A review of canine inherited bleeding disorders: biochemical and molecular strategies for disease characterization and carrier detection. J. Hered. 1999, 90:112-118.
8. Brooks MB, Catalfamo JL, Brown HA, Ivanova P, Lovaglio J. A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity. Blood. 2002, 99:2434-2441.
9. Brooks MB, Catalfamo JL, Friese P, Dale GL. Scott syndrome dogs have impaired coated-platelet formation and calcein-release but normal mitochondrial depolarization. J. Thromb. Haemost. 2007, 5:1972-1974.
10. Castaman G, Yu-Feng L, Battistin E, Rodeghiero F. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br. J. Haematol. 1997, 96:458-463.
11. Castelhano M.G, et al. Development and use of DNA archives at veterinary teaching hospitals to investigate the genetic basis of disease in dogs. J. Am. Vet. Med. Assoc. 2009, 234:75-80.
12. Catalfamo JL, Brooks MB, Ammersbach M, deMaster A. Platelet ABCA1 expression is normal in Scott syndrome dogs. Blood. 2006, 108:57b.
13. Clark L.A, et al. Chromosome-specific microsatellite multiplex sets for linkage studies in the domestic dog. Genomics. 2004, 84:550-554.
14. Dachary-Prigent J, Pasquet JM, Freyssinet JM, Nurden AT. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Biochemistry. 1995, 34:11625-11634.
15. Dale GL, Friese P. Bax activators potentiate coated-platelet formation. J. Thromb. Haemost. 2006, 4:2664-2669.
16. Dittrich M, et al. Platelet protein interactions: map, signaling components, and phosphorylation groundstate. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1326-1331.
17. Goodstadt L, Ponting CP. Phylogenetic reconstruction of orthology, paralogy, and conserved synteny for dog and human. PLoS Comput. Biol. 2006, 2:e133.
18. Guyon R, et al. A 1-Mb resolution radiation hybrid map of the canine genome. Proc. Natl. Acad. Sci. USA. 2003, 100:5296-5301.
19. Heemskerk JW, Siljander PR, Bevers EM, Farndale RW, Lindhout T. Receptors and signalling mechanisms in the procoagulant response of platelets. Platelets. 2000, 11:301-306.
20. Janel N, et al. Assessment of the expression of candidate human plasma membrane phospholipid scramblase in Scott syndrome cells. Thromb. Haemost. 1999, 81:322-323.
21. Jobe S.M, et al. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood. 2008, 111:1257-1265.
22. Lopez JJ, Salido GM, Pariente JA, Rosado JA. Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets. J. Thromb. Haemost. 2008, 6:1780-1788.
23. Nofer J.R, et al. Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease). J. Biol. Chem. 2004, 279:34032-34037.
24. Ostrander EA, Kruglyak L. Unleashing the canine genome. Genome Res. 2000, 10:1271-1274.
25. Sahu SK, Gummadi SN, Manoj N, Aradhyam GK. Phospholipid scramblases: an overview. Arch. Biochem. Biophys. 2007, 462:103-114.
26. Salles I.I, et al. Inherited traits affecting platelet function. Blood Rev. 2008, 22:155-172.
27. Schmitz G, Schambeck CM. Molecular defects in the ABCA1 pathway affect platelet function. Pathophysiol. Haemost. Thromb. 2006, 35:166-174.
28. Schoenwaelder S.M, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood. 2009, 114:663-666.
29. Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb. Haemost. 2001, 86:266-275.
30. Smith DJ, Ng H, Kluck RM, Nagley P. The mitochondrial gateway to cell death. IUBMB Life. 2008, 60:383-389.
31. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood. 1996, 87:1409-1415.
32. van der Planken M.G, et al. Platelet prothrombinase activity, a final pathway platelet procoagulant activity, is overexpressed in type 1 diabetes: no relationship with mean platelet volume or background retinopathy. Clin. Appl. Thromb. Hemost. 2000, 6:65-68.
33. Weiss HJ. Impaired platelet procoagulant mechanisms in patients with bleeding disorders. Semin. Thromb. Hemost. 2009, 35:233-241.
34. Zarubica A, Trompier D, Chimini G. ABCA1, from pathology to membrane function. Pflugers Arch. 2007, 453:569-579.
35. Zhou Q, Sims PJ, Wiedmer T. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome. Blood. 1998, 92:1707-1712.
36. Zhou Q, et al. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J. Biol. Chem. 1997, 272:18240-18244.
37. Zhou Q, Zhao J, Wiedmer T, Sims PJ. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood. 2002, 99:4030-4038.
38. Zwaal RF, Comfurius P, Bevers EM. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim. Biophys. Acta. 1992, 1180:1-8.
39. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim. Biophys. Acta. 2004, 1636:119-128.